Free Trial

Context Therapeutics (CNTX) SEC Filings & 10K Form

Context Therapeutics logo
$0.86 +0.10 (+13.22%)
Closing price 03/25/2025 04:00 PM Eastern
Extended Trading
$0.96 +0.09 (+10.64%)
As of 03/25/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Context Therapeutics SEC Filings

DateFilerForm TypeView
03/20/2025
3:44 PM
Context Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/28/2025
3:06 PM
Context Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
9:02 AM
Avidity Partners Management LP (Filed by)
Context Therapeutics (Subject)
Form SCHEDULE 13G/A
02/14/2025
5:27 AM
Context Therapeutics (Subject)
Opaleye Management Inc. (Filed by)
Form SCHEDULE 13G/A
02/12/2025
4:20 PM
Context Therapeutics (Subject)
Lehr Martin A. (Filed by)
Form SCHEDULE 13G/A
01/27/2025
11:55 AM
Context Therapeutics (Subject)
FRANKLIN RESOURCES INC (Filed by)
Form SCHEDULE 13G
01/14/2025
7:36 PM
Context Therapeutics (Issuer)
Pasternak Andy (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/14/2025
7:43 PM
Context Therapeutics (Issuer)
Pasternak Andy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
4:03 PM
Context Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
6:37 AM
Context Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
3:07 PM
Context Therapeutics (Subject)
MPM BioImpact LLC (Filed by)
Form SCHEDULE 13G
12/23/2024
8:26 AM
Context Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2024
3:20 PM
Context Therapeutics (Filer)
Form 424B5
12/02/2024
3:21 PM
Context Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
11:15 PM
Context Therapeutics (Filer)
Form EFFECT
11/14/2024
3:52 PM
Context Therapeutics (Subject)
GREAT POINT PARTNERS LLC (Filed by)
Form SC 13G/A
11/06/2024
4:08 PM
Context Therapeutics (Subject)
Hudson Bay Capital Management LP (Filed by)
Form SC 13G/A
11/06/2024
3:42 PM
Context Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
09/23/2024
6:33 AM
Context Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2024
3:22 PM
Context Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
7:15 AM
Context Therapeutics (Issuer)
Smith Karen L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
7:01 AM
Context Therapeutics (Issuer)
Walker Luke Nathaniel (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/05/2024
7:04 AM
Context Therapeutics (Issuer)
Walker Luke Nathaniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
7:08 AM
Context Therapeutics (Issuer)
Smith Karen L. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/04/2024
6:34 AM
Context Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2024
4:15 PM
Context Therapeutics (Issuer)
Dansky Ullmann Claudio (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/01/2024
4:18 PM
Context Therapeutics (Issuer)
Dansky Ullmann Claudio (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2024
4:07 PM
Context Therapeutics (Filer)
Form DEFA14A
07/24/2024
3:55 PM
Context Therapeutics (Filer)
Form DEF 14A
07/10/2024
6:33 AM
Context Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
6:52 AM
Context Therapeutics (Issuer)
Stacey Jennifer Evans (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
6:41 AM
BERMAN RICHARD J (Reporting)
Context Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
6:47 AM
Context Therapeutics (Issuer)
West Linda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
6:50 AM
Context Therapeutics (Issuer)
Kantoff Philip W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
6:34 AM
Context Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2024
9:45 AM
Context Therapeutics (Subject)
GREAT POINT PARTNERS LLC (Filed by)
Form SC 13G
06/02/2024
11:15 PM
Context Therapeutics (Filer)
Form EFFECT
05/24/2024
6:31 AM
Context Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/13/2024
9:37 AM
Avidity Partners Management LP (Filed by)
Context Therapeutics (Subject)
Form SC 13G
05/02/2024
6:37 AM
Context Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2024
3:16 PM
Context Therapeutics (Filer)
Form ARS
AI Boom Takes a Shocking Turn… (Ad)

AI is Creating Fortunes… (but not where you think!) Bryce Paul and the team at Crypto101 just released a brand-new report…

The #1 AI Coin for 2025 (Click here to access it now)
04/26/2024
3:12 PM
Context Therapeutics (Filer)
Form DEFA14A
04/01/2024
6:32 AM
Context Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:CNTX) was last updated on 3/26/2025 by MarketBeat.com Staff
From Our Partners